Penn Medicine Healthy Heart

计划入组 1,980 人 · 首次发布于 2023 年 10 月 2 日

Penn State TXT2Quit Study

计划入组 152 人 · 首次发布于 2015 年 2 月 20 日

Penn SICCA Follow-up Study

计划入组 220 人 · 首次发布于 2021 年 9 月 24 日

HBx(Seed Therapeutics)

FEN1(Seed Therapeutics)

RBM39(Seed Therapeutics)

Seed Therapeutics, Inc.

United States

Innovative Cellular Therapeutics Inc

United States

Innovative Cellular Therapeutics Co., Ltd.

China

University of Pennsylvania, BioNTech, and OUP Launch $50 Million Life Sciences Venture Fund

Penn Medicine Receives $50 Million Gift to Fund Early-Stage Cancer, Autoimmune and Infectious Disease Research

Recursion CEO Launches $250K Pre-Seed Fund to Counter NIH Funding Cuts